{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:10:20Z","timestamp":1789477820420,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bbi.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T16:36:57Z","timestamp":1717864617000},"page":"304-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-3924","authenticated-orcid":false,"given":"Ming-Fen","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Cohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Tuncturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Heider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Skime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada M","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Skillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Oesterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Karpyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Weinshilboum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.06.007_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbi.2020.08.002","article-title":"Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis","volume":"89","author":"Adams","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.bbi.2024.06.007_b0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2265.2007.03125.x","article-title":"Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease","volume":"68","author":"Ahmed","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"17","key":"10.1016\/j.bbi.2024.06.007_b0015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: The combine study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.bbi.2024.06.007_b0020","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41386-021-01097-0","article-title":"Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study","volume":"46","author":"Biernacka","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.bbi.2024.06.007_b0025","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/hmg\/ddaa038","article-title":"Single cell transcriptome profiling of the human alcohol-dependent brain","volume":"29","author":"Brenner","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2024.06.007_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.822290","article-title":"Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sj\u00f6gren's Syndrome","volume":"9","author":"Casad\u00f3-Llombart","year":"2022","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.bbi.2024.06.007_b0035","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","article-title":"Psychiatric comorbidities in alcohol use disorder","volume":"6","author":"Castillo-Carniglia","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.007_b0040","article-title":"Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis","volume":"371","author":"Cheng","year":"2020","journal-title":"BMJ (clinical Research Ed)."},{"issue":"10","key":"10.1016\/j.bbi.2024.06.007_b0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cmi.2017.119","article-title":"Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis","volume":"15","author":"Consuegra-Fern\u00e1ndez","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2024.06.007_b0050","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1038\/ctg.2016.34","article-title":"Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association Loci","volume":"7","author":"Di Narzo","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbi.2024.06.007_b0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ijnp\/pyac014","article-title":"Effect of Glucocorticoid and 11\u03b2-Hydroxysteroid-Dehydrogenase Type 1 (11\u03b2-HSD1) in Neurological and Psychiatric Disorders","volume":"25","author":"Dodd","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0060","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1038\/ncomms5684","article-title":"Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs","volume":"5","author":"Enroth","year":"2014","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bbi.2024.06.007_b0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiat."},{"issue":"12","key":"10.1016\/j.bbi.2024.06.007_b0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/mp.2016.6","article-title":"TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics","volume":"21","author":"Gupta","year":"2016","journal-title":"Mol Psychiatry."},{"issue":"6","key":"10.1016\/j.bbi.2024.06.007_b0075","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/adb.12425","article-title":"Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies","volume":"22","author":"Hendershot","year":"2017","journal-title":"Addict. Biol."},{"issue":"8","key":"10.1016\/j.bbi.2024.06.007_b0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1517\/13543784.2011.592139","article-title":"Opioid modulators for alcohol dependence","volume":"20","author":"Hillemacher","year":"2011","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bbi.2024.06.007_b0085","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1038\/s41380-020-0855-9","article-title":"TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response","volume":"26","author":"Ho","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.06.007_b0090","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1038\/s41380-020-0855-9","article-title":"TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response","volume":"26","author":"Ho","year":"2021","journal-title":"Mol Psychiatry."},{"issue":"986238","key":"10.1016\/j.bbi.2024.06.007_b0095","article-title":"Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder","volume":"13","author":"Ho","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2024.06.007_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101534","article-title":"Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: molecular links between the SNHG16 locus and catecholamine metabolism","volume":"63","author":"Ho","year":"2022","journal-title":"Molecular Metabolism."},{"issue":"13","key":"10.1016\/j.bbi.2024.06.007_b0105","first-page":"16","article-title":"Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study","volume":"173","author":"Ho","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2024.06.007_b0110","article-title":"Epigenetic regulation of GABA catabolism in iPSC-derived neurons: the molecular links between FGF21 and histone methylation","volume":"101798","author":"Ho","year":"2023","journal-title":"Molecular Metabolism."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41398-024-02880-5","article-title":"Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study","volume":"14","author":"Ho","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2024.06.007_b0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional Specialization of Interleukin-17 Family Members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbi.2024.06.007_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bcp.12348","article-title":"Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations","volume":"78","author":"Ji","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2024.06.007_b0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/gene.2009.81","article-title":"Multiple sclerosis susceptibility alleles in African Americans","volume":"11","author":"Johnson","year":"2010","journal-title":"Genes Immun."},{"issue":"18","key":"10.1016\/j.bbi.2024.06.007_b0135","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.bbi.2024.06.007_b0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcp.12070","article-title":"The clinical pharmacology of acamprosate","volume":"77","author":"Kalk","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbi.2024.06.007_b0145","article-title":"Disulfiram in the management of alcohol dependence: A comprehensive clinical review. Open","volume":"04No.01:10","author":"Kalra","year":"2014","journal-title":"J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41398-019-0384-y","article-title":"Analysis of whole genome-transcriptomic organization in brain to identify genes associated with alcoholism","volume":"9","author":"Kapoor","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2024.06.007_b0155","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/acer.14712","article-title":"Exploring relationships between alcohol consumption, inflammation, and brain structure in a heavy drinking sample","volume":"45","author":"Karoly","year":"2021","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.bbi.2024.06.007_b0160","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1038\/tp.2014.103","article-title":"Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate","volume":"4","author":"Karpyak","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0165","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41467-019-09480-8","article-title":"Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations","volume":"10","author":"Kranzler","year":"2019","journal-title":"Nat Commun."},{"issue":"12","key":"10.1016\/j.bbi.2024.06.007_b0170","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor\u2013based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/acer.14233","article-title":"Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice","volume":"44","author":"Litten","year":"2020","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41398-017-0056-8","article-title":"Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics","volume":"8","author":"Liu","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12974-020-01972-5","article-title":"Chronic alcohol-induced neuroinflammation involves CCR2\/5-dependent peripheral macrophage infiltration and microglia alterations","volume":"17","author":"Lowe","year":"2020","journal-title":"J Neuroinflammation."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.007_b0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.bbi.2024.06.007_b0195","first-page":"127","article-title":"Challenges and Future Prospects of Precision Medicine in Psychiatry","volume":"13","author":"Manchia","year":"2020","journal-title":"Pharmgenomics Pers Med."},{"issue":"4","key":"10.1016\/j.bbi.2024.06.007_b0200","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1530-0277.2008.00884.x","article-title":"Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study","volume":"33","author":"Mann","year":"2009","journal-title":"Alcohol Clin Exp Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/187152710790966641","article-title":"Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence","volume":"9","author":"Mason","year":"2010","journal-title":"CNS Neurol Disord Drug Targets."},{"issue":"4","key":"10.1016\/j.bbi.2024.06.007_b0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/alcalc\/35.4.324","article-title":"KINETIC STUDY OF ACAMPROSATE ABSORPTION IN RAT SMALL INTESTINE","volume":"35","author":"M\u00e1s-Serrano","year":"2000","journal-title":"Alcohol Alcohol."},{"issue":"6","key":"10.1016\/j.bbi.2024.06.007_b0215","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/add.13311","article-title":"Association between a brief alcohol craving measure and drinking in the following week","volume":"111","author":"McHugh","year":"2016","journal-title":"Addiction"},{"issue":"17","key":"10.1016\/j.bbi.2024.06.007_b0220","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2024.06.007_b0225","doi-asserted-by":"crossref","unstructured":"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, et al. 11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proceedings of the National Academy of Sciences. 2014;111(24):E2482-E91.","DOI":"10.1073\/pnas.1323681111"},{"key":"10.1016\/j.bbi.2024.06.007_b0230","doi-asserted-by":"crossref","unstructured":"Moura HF, Hansen F, Galland F, Silvelo D, Rebelatto FP, Ornell F, et al. Inflammatory cytokines and alcohol use disorder: systematic review and meta-analysis. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2022;44(5):548-56.","DOI":"10.47626\/1516-4446-2021-1893"},{"issue":"10","key":"10.1016\/j.bbi.2024.06.007_b0235","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.mayocp.2019.03.029","article-title":"Medication-Assisted Treatment for Opioid-Use Disorder","volume":"94","author":"Oesterle","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.bbi.2024.06.007_b0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bpa.12548","article-title":"Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: A post-mortem study","volume":"28","author":"Qi","year":"2018","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.007_b0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS Neurol Disord Drug Targets."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.007_b0250","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1038\/tp.2016.13","article-title":"11\u03b2-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse","volume":"6","author":"Sanna","year":"2016","journal-title":"Transl Psychiatry."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.007_b0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/npr2.12028","article-title":"Anticraving therapy for alcohol use disorder: A clinical review","volume":"38","author":"Shen","year":"2018","journal-title":"Neuropsychopharmacology Reports."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.007_b0260","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbi.2024.06.007_b0265","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbi.2024.06.007_b0270","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat Commun."},{"key":"10.1016\/j.bbi.2024.06.007_b0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/TCRM.S23184","article-title":"Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility","volume":"8","author":"Witkiewitz","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bbi.2024.06.007_b0280","article-title":"Advances in the science and treatment of alcohol use disorder","author":"Witkiewitz","year":"2019594043","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.007_b0285","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.20141702","article-title":"Targeting IL-17B\u2013IL-17RB signaling with an anti\u2013IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines","volume":"212","author":"Wu","year":"2015","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.007_b0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131277","article-title":"Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice","volume":"5","author":"Xu","year":"2020","journal-title":"JCI Insight."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T19:09:40Z","timestamp":1721675380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124004471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":58,"alternative-id":["S0889159124004471"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.06.007","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}